MED II, managed by ArchiMed SAS, completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million on May 13, 2019. The deal included 13.5 million Class A shares for €13.3 million.
ENDATA